4335 related articles for article (PubMed ID: 7516926)
1. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
2. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
[TBL] [Abstract][Full Text] [Related]
3. A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses.
Olsen AC; Fossum B; Kirkin AF; Zeuthen J; Gaudernack G
Scand J Immunol; 1995 Apr; 41(4):357-64. PubMed ID: 7899823
[TBL] [Abstract][Full Text] [Related]
4. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
[TBL] [Abstract][Full Text] [Related]
5. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.
Robbins PF; El-Gamil M; Li YF; Zeng G; Dudley M; Rosenberg SA
J Immunol; 2002 Nov; 169(10):6036-47. PubMed ID: 12421991
[TBL] [Abstract][Full Text] [Related]
6. A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.
Somasundaram R; Swoboda R; Caputo L; Lee A; Jackson N; Marincola FM; Guerry D; Herlyn D
Int J Cancer; 2003 Apr; 104(3):362-8. PubMed ID: 12569560
[TBL] [Abstract][Full Text] [Related]
7. Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers.
Bioley G; Jandus C; Tuyaerts S; Rimoldi D; Kwok WW; Speiser DE; Tiercy JM; Thielemans K; Cerottini JC; Romero P
J Immunol; 2006 Nov; 177(10):6769-79. PubMed ID: 17082590
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyte.
Nishimura MI; Avichezer D; Custer MC; Lee CS; Chen C; Parkhurst MR; Diamond RA; Robbins PF; Schwartzentruber DJ; Rosenberg SA
Cancer Res; 1999 Dec; 59(24):6230-8. PubMed ID: 10626817
[TBL] [Abstract][Full Text] [Related]
9. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
[TBL] [Abstract][Full Text] [Related]
10. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
[TBL] [Abstract][Full Text] [Related]
11. HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes.
Le Dréan E; Gervois N; Diez E; Semana G; Dreno B; Jotereau F
Eur J Immunol; 1995 Oct; 25(10):2732-6. PubMed ID: 7589064
[TBL] [Abstract][Full Text] [Related]
12. Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen.
Novellino L; Renkvist N; Rini F; Mazzocchi A; Rivoltini L; Greco A; Deho P; Squarcina P; Robbins PF; Parmiani G; Castelli C
J Immunol; 2003 Jun; 170(12):6363-70. PubMed ID: 12794170
[TBL] [Abstract][Full Text] [Related]
13. Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II molecules.
Parkhurst MR; DePan C; Riley JP; Rosenberg SA; Shu S
J Immunol; 2003 May; 170(10):5317-25. PubMed ID: 12734382
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
15. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells.
Chen M; Shirai M; Liu Z; Arichi T; Takahashi H; Nishioka M
J Virol; 1998 Oct; 72(10):8301-8. PubMed ID: 9733874
[TBL] [Abstract][Full Text] [Related]
16. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
17. Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
Kharkevitch DD; Seito D; Balch GC; Maeda T; Balch CM; Itoh K
Int J Cancer; 1994 Aug; 58(3):317-23. PubMed ID: 7914181
[TBL] [Abstract][Full Text] [Related]
18. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
Enssle KH; Fleischer B
Clin Exp Immunol; 1990 Mar; 79(3):409-15. PubMed ID: 1690617
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus vector-mediated expression of tumor-associated epitopes by human antigen presenting cells.
Lizée G; Gonzales MI; Topalian SL
Hum Gene Ther; 2004 Apr; 15(4):393-404. PubMed ID: 15053864
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T-cell clones recognizing human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
Long HM; Zuo J; Leese AM; Gudgeon NH; Jia H; Taylor GS; Rickinson AB
Blood; 2009 Jul; 114(4):807-15. PubMed ID: 19443664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]